Skip to content

Comparison of 2 Hyperglycemia-correction Scales in Hospitalized Patients

Comparison of 2 Hyperglycemia-correction Scales in Hospitalized Patients in an Institution in Bogotá, Colombia

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05752929
Acronym
CAPADOCIA1
Enrollment
116
Registered
2023-03-03
Start date
2016-01-01
Completion date
2019-12-31
Last updated
2023-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabete Type 2, Hyperglycemia

Keywords

Diabetes mellitus, hyperglycemia, hospitalization, treatment, hypoglycemia

Brief summary

Hyperglycemia in the hospital is associated with multiple adverse outcomes. Previously, the mobile insulin scheme was used for its control. However, in the last decade, several studies have shown that the insulin basal-bolus (basal plus) regimen is associated with better glycemic control and a lower risk of hypoglycemia.

Detailed description

Introduction: Hyperglycemia in the hospital is associated with multiple adverse outcomes. Previously, the mobile insulin scheme was used for its control. However, in the last decade, several studies have shown that the insulin basal-bolus (basal plus) regimen is associated with better glycemic control and a lower risk of hypoglycemia. Objective: To compare the sensitive scheme of Umpierrez and the correction factor suggested by Davidson (1700/total dose of insulin) for the correction of hyperglycemia in patients with type 1 diabetes mellitus. Methods: Unblinded, randomized, controlled clinical trial in patients with hyperglycemia and type 2 diabetes mellitus hospitalized at a hospital in Bogotá, Colombia, between 2016 and 2018. A probabilistic sampling with randomly permuted blocks was performed. The Umpierrez sensitive correction scheme and the Davidson correction factor were compared by evaluating glycemic control at 2 and 5 hours, and the presence of hypoglycemia.

Interventions

DRUGInsulin

correction scheme with Rapid Acting Insulin Analogs according with the Umpierrez sensitive correction scheme

DRUGinsulin

correction scheme with Rapid Acting Insulin Analogs according with the Davidson correction scheme

Sponsors

Hospital Universitario Clinica San Rafael
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Unblinded, randomized, controlled clinical trial in patients with hyperglycemia and type 2 diabetes mellitus hospitalized

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients with diabetes mellitus who presented hyperglycemia (above 140 mg/dl) located in the general ward, emergency room or hospitalization and who received a basal or basal bolus insulin scheme.

Exclusion criteria

* pregnancy, with acute decompensation of diabetes (diabetic ketoacidosis-hyperosmolar state) or type 1 diabetes

Design outcomes

Primary

MeasureTime frameDescription
Number of paticipants with Glicemic control5 hoursGlycemic control defined as glucose levels between 70 and 180 mg/dl measured with a glucometer

Secondary

MeasureTime frameDescription
Number of participants with hypoglycemia6 hourshypoglycemia defined as glucose levels less than 70 mg/dl measured with a glucometer

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026